MedTrace Logo

Acute Postprandial Effects of Functional Ice Cream With Cimarrón Bean Extrudate in Adults

NCT07053267 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2025-07-08

No results posted yet for this study

Summary

The goal of this non-randomized clinical trial is to evaluate the acute postprandial metabolic effects of a functional ice cream enriched with Cimarrón bean (Phaseolus vulgaris L. local variety Cimarrón) extrudate in adults with at least one cardiovascular risk factor.

The main questions it aims to answer are:

* Does the functional ice cream reduce postprandial glucose and insulin levels?
* Does it affect postprandial lipid concentrations?

Researchers will compare participants receiving a single dose of the functional ice cream containing 10 g of extrudate per 100 g to placebo version without extrudate, both ice creams are identical in appearance and taste.

Participants will:

* Attend a clinical visit in fasting conditions (10-12 hours).
* Provide baseline blood samples for glucose, insulin, and lipid profile.
* Consume a single 100 g portion of functional or placebo ice cream.
* Provide postprandial blood samples at defined time points.

Conditions

  • Cardiovascular Disease Risk Factor
  • Insulin Resistance
  • Overweight (BMI > 25)
  • Hyperglycaemia

Interventions

DIETARY_SUPPLEMENT

Funrional Ice Cream

Single 100 g serving of ice cream enriched with 10 g of Cimarrón bean extrudate, administered after an overnight fast to evaluate postprandial metabolic responses.

DIETARY_SUPPLEMENT

Placebo Ice Cream

Single 100 g serving of placebo ice cream identical in flavor, texture, and appearance, but without Cimarrón bean extrudate, administered after an overnight fast to evaluate postprandial metabolic responses.

Sponsors & Collaborators

  • Centro de Estudios en Alimentos Procesados

    collaborator OTHER

  • University of Talca

    lead OTHER

Principal Investigators

  • Ivan F Palomo González, PhD. Biomedical Science · University of Talca

  • Eduardo J Fuentes Quinteros, PhD. Science research · University of Talca

Study Design

Allocation
NON_RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
59 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-05-26
Primary Completion
2025-05-30
Completion
2025-05-30

Countries

  • Chile

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07053267 on ClinicalTrials.gov